Hoya Corp
SWB:HYB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Hoya Corp (HYB) under the Base Case is EUR per share.
Compared with the current market price of 132.35 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Hoya Does
Hoya Corp makes high-precision products that sit at the center of modern optics and healthcare. Its business is built around two main areas: eye care and medical devices, plus specialty materials and components for the electronics industry. In eye care, it sells eyeglass lenses, contact lenses, and related optical products. In healthcare, it sells endoscopes and intraocular lenses used in cataract surgery, while its materials business supplies advanced glass and related parts used in manufacturing and semiconductor work.
- Headquarters
- Japan JP
- Employees
- 37 909
- IPO date
- Oct 2, 1961
Hoya has a narrow economic moat
Replacing Hoya’s approved materials in advanced chipmaking requires testing and carries production risks, giving customers a reason to stay with a proven supplier. Patented designs also protect specialized eyeglass lenses from direct copying, although these protections apply to particular products rather than everything Hoya sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Hoya Corp
Earnings Waterfall
Hoya Corp
Continue HYB Research
Decided on Hoya? Get an email when HYB reaches the price you’d buy at. Free with an account.
Other Hoya listings
What is the Intrinsic Value of one HYB stock?
The intrinsic value for Hoya Corp (HYB) under the Base Case is EUR.
Is HYB stock undervalued or overvalued?
Compared with the current market price of 132.35 EUR, the stock appears .
